Show simple item record

dc.contributor.authorHatton, Graceen
dc.contributor.authorAlterio, Tommasoen
dc.contributor.authorNobili, Valerioen
dc.contributor.authorMann, Jakeen
dc.date.accessioned2018-08-20T12:30:02Z
dc.date.available2018-08-20T12:30:02Z
dc.date.issued2018-10en
dc.identifier.issn1747-4124
dc.identifier.urihttps://www.repository.cam.ac.uk/handle/1810/278960
dc.description.abstractIntroduction: Paediatric non-alcoholic fatty liver disease (NAFLD) is common disorder that has complex pathophysiology and unquantified clinical significance. Though there have been major advances in the field there is much yet to be understood. Areas covered: PubMed/MEDLINE and Embase were searched for articles related to paediatric NAFLD and non-alcoholic steatohepatitis between January 1998 and January 2018. The areas considered to be “unmet needs” were: The relationship between the intestinal microbiome and perinatal events; clinical event risk stratification; and mechanisms underlying portal inflammation. Expert commentary: In utero and ex utero factors have been associated with NAFLD and also with the intestinal microbiome, but it is not yet known how intestinal dysbiosis can be reversed and whether intervention in high-risk neonates could alter their propensity for the metabolic syndrome. Children with NAFLD are at increased risk of cardiovascular, diabetic, and hepatic diseases, but it is unclear how best to stratify children into appropriate risk groups for targeted interventions. Finally, the immune processes underlying paediatric NASH are thought to differ to those in adult NASH, yet the events surrounding activation of periportal lymphocytes are poorly understood. Deepening our understanding of these topics may lead to novel therapeutic targets.
dc.format.mediumPrint-Electronicen
dc.languageengen
dc.titleUnmet needs in pediatric NAFLD research: what do we need to prioritize for the future?en
dc.typeArticle
prism.endingPage967
prism.issueIdentifier10en
prism.publicationDate2018en
prism.publicationNameExpert review of gastroenterology & hepatologyen
prism.startingPage961
prism.volume12en
dc.identifier.doi10.17863/CAM.26342
dcterms.dateAccepted2018-08-14en
rioxxterms.versionofrecord10.1080/17474124.2018.1512853en
rioxxterms.versionAM*
rioxxterms.licenseref.urihttp://www.rioxx.net/licenses/all-rights-reserveden
rioxxterms.licenseref.startdate2018-10en
dc.contributor.orcidMann, Jake [0000-0002-4711-9215]
dc.identifier.eissn1747-4132
rioxxterms.typeJournal Article/Reviewen
rioxxterms.freetoread.startdate2019-08-17


Files in this item

Thumbnail

This item appears in the following Collection(s)

Show simple item record